The article explains how veterinary rehabilitation supports recovery, improves mobility, and helps pets maintain long-term function after injury or illness.

KEARNEY, Neb., Aug. 4, 2026 /PRNewswire/ — What are the real benefits of pet rehabilitation for pets recovering from surgery, injury, or chronic health conditions? HelloNation answers that question in a HelloNation article featuring insights from Veterinary Experts Drs. Brandon and Paola Beebout of Kearney, Nebraska. The article explains how pet rehab combines targeted exercises, therapeutic treatments, and medical oversight to improve healing, restore mobility, and enhance quality of life for animals at every stage of recovery.

The HelloNation article explains that rehabilitation is more than a way to help pets recover after surgery. It describes a personalized process that addresses pain, weakness, balance, and mobility while helping pets regain confidence in their movement. By tailoring rehabilitation plans to each animal’s condition and progress, veterinary teams can support safer, more effective healing and reduce the likelihood of future injuries.

According to the article, pet rehab often includes carefully supervised therapeutic exercises designed to rebuild muscle strength and improve joint function. Activities such as controlled leash walking, range-of-motion exercises, and core strengthening help pets regain movement while protecting healing tissues. The article notes that these exercises are adjusted throughout recovery to match each pet’s changing abilities and medical needs.

The article also describes several supportive therapies that work alongside exercise to improve comfort and healing. Hydrotherapy allows dogs to exercise with less stress on their joints while strengthening muscles and improving endurance. Laser therapy is highlighted as another treatment that can reduce discomfort and support tissue healing. Together, these therapies help pets participate more comfortably in the rehabilitation process while promoting steady progress.

Beyond post-surgical recovery, the HelloNation article explains that rehabilitation can play an important role in managing chronic orthopedic and neurological conditions. Pets living with arthritis, vestibular disease, or other progressive disorders may benefit from exercises that improve balance, coordination, and stability. The article describes how these therapies help many animals maintain independence and enjoy daily activities for longer periods despite ongoing medical challenges.

Veterinary Experts Drs. Brandon and Paola Beebout also emphasize in the article that successful rehabilitation extends beyond appointments at the veterinary clinic. Pet owners become active participants by learning safe techniques to continue prescribed exercises at home. The article explains that this partnership helps reinforce progress made during therapy sessions while reducing the risk of setbacks or re-injury between visits.

The HelloNation article further notes that regular monitoring allows rehabilitation plans to evolve as pets improve. Adjustments to exercise intensity, treatment frequency, and therapeutic goals ensure that each stage of recovery reflects the pet’s current condition rather than following a one-size-fits-all approach. This individualized care helps maximize both comfort and long-term function.

Throughout the article, Veterinary Experts Drs. Brandon and Paola Beebout demonstrate how pet rehab serves a wide range of patients, from animals recovering after orthopedic surgery to those living with chronic disease. The article concludes that combining medical supervision with customized therapy and owner involvement creates stronger outcomes by helping pets regain mobility, manage pain, and maintain healthier, more active lives.

How Pet Rehab Relieves Pain and Builds Strength features insights from Drs. Brandon and Paola Beebout, Veterinary Experts of Kearney, Nebraska, in HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-veterinary-experts-drs-brandon-and-paola-beebout-explain-how-pet-rehab-relieves-pain-and-builds-strength-302842975.html

SOURCE HelloNation

WILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ — The Chemours Company (“Chemours”) (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company’s common stock for the third quarter of 2026. The dividend will be paid on September 15, 2026, to stockholders of record as of the close of business on August 14, 2026.

About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn. 

CONTACTS:

INVESTORS
Brandon Ontjes
VP, Head of Strategy & Investor Relations
+1.302.773.3300 
investor@chemours.com 

NEWS MEDIA
Cassie Olszewski
Media Relations & Reputation Leader
+1.302.219.7140
media@chemours.com  

View original content to download multimedia:https://www.prnewswire.com/news-releases/chemours-announces-third-quarter-dividend-302842840.html

SOURCE The Chemours Company

WILMINGTON, Del., August 4, 2026 /PRNewswire/ — Oak-Eagle AcquireCo, Inc. (the “Offeror”) announced today the final results as of 5:00 P.M., New York City time, on July 30, 2026 (the “Expiration Time”), for the previously announced offers to purchase for cash (each, a “Tender Offer” and, together, the “Tender Offers”) any and all of Electronic Arts Inc.’s (the “Company”) outstanding (i) 1.850% Senior Notes due 2031 (the “2031 Notes”) and (ii) 2.950% Senior Notes due 2051 (the “2051 Notes” and, together with the 2031 Notes, the “Notes”), and the related solicitations of consents (each, a “Consent Solicitation” and, together, the “Consent Solicitations”).

The Tender Offers and the Consent Solicitations were made in connection with, and were expressly conditioned upon the closing of, the acquisition of the Company pursuant to the Agreement and Plan ‎of Merger, dated September 28, 2025 (as it may be amended, supplemented or modified from time to ‎time, the “Merger Agreement”), by and among the Company, the Offeror and Oak-Eagle MergerCo, Inc., a Delaware corporation and a wholly-owned subsidiary of the Offeror (“Merger Sub”), pursuant to which Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly-owned subsidiary of the Offeror, in each case on and subject to the terms and conditions therein. The Offeror and Merger Sub were formed by an investor consortium consisting of The Public Investment Fund, Silver Lake and Affinity Partners, for purposes of engaging in the transactions contemplated by the Merger Agreement.

The table below outlines the approximate principal amount of the Notes validly tendered and not validly withdrawn as of the Expiration Time, according to information provided by Global Bondholder Services Corporation, the depositary and information agent for the Tender Offers and the Consent Solicitations (the “Depositary and Information Agent”). The Tender Offers settled on August 4, 2026. Capitalized terms used herein, but not otherwise defined, have the meanings ascribed to such terms in the Offer to Purchase and Consent Solicitation Statement.

(1) The CUSIP numbers and ISINs referenced in this press release are included solely for the convenience of Holders. None of the Offeror, the Company, the Trustee, the Dealer Manager (as defined below), the Depositary and Information Agent nor their respective affiliates shall be held responsible for the selection or use of the referenced CUSIP numbers and ISINs, and no representation is made as to the correctness of any CUSIP number or ISIN on the Notes or as indicated in this press release or any other document.

The Offeror has caused the Company to defease certain obligations under the Indenture with respect to the outstanding Notes not tendered and purchased pursuant to the Tender Offers, in accordance with the terms of the Indenture. To effect the defeasance, the Company irrevocably deposited U.S. Government Obligations with the Trustee in a defeasance trust fund for the benefit of the holders of such outstanding Notes in amounts sufficient to pay principal of, premium, if any, and interest on such Notes when due. As a result of the defeasance, the Company may omit to comply with certain terms, provisions and conditions set forth in certain covenants with respect to the Notes, and related events of default shall be deemed not to be events of default with respect to the Notes.

General Information

J.P. Morgan Securities LLC was the dealer manager in connection with the Tender Offers and solicitation agent in connection with the Consent Solicitations (the “Dealer Manager”).

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful.

J.P. Morgan Securities LLC has been retained as the dealer manager in connection with the Tender Offers and as the solicitation agent in connection with the Consent Solicitations (the “Dealer Manager”). In such capacities, it may contact Holders regarding the Tender Offers and the Consent Solicitations and may request brokers, dealers, commercial banks, trust companies and other nominees to forward the Offer to Purchase and Consent Solicitation Statement and related materials to beneficial owners of Notes. Requests for documents may be directed to the Depositary and Information Agent at: +1 (855) 654 2015 or contact@gbsc-usa.com. Questions about the Tender Offers and the Consent Solicitations may be directed to J.P. Morgan Securities LLC at (866) 834-4466 or (212) 834-3424.

View original content:https://www.prnewswire.com/news-releases/oak-eagle-acquireco-inc-announces-final-results-and-settlement-of-the-previously-announced-tender-offers-and-consent-solicitations-for-any-and-all-of-electronic-arts-incs-1-850-senior-notes-due-2031-and-2-950-senior-notes-du-302842978.html

SOURCE Oak-Eagle AcquireCo, Inc.